Cipla Investor Relations Material
Latest events
Q3 23/24
Cipla
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Cipla Limited
Access all reports
Cipla Limited develops, manufactures, and markets pharmaceuticals products in India, the United States, South Africa, and internationally. It offers active pharmaceutical ingredients (APIs) and intermediates that comprise anesthetics/sedatives; analytical reference standards; antiretrovirals/antiretroviral intermediates; anticancer/oncology related APIs and intermediates; cardiovascular; dermatological, hair fall control drugs; diabetology; erectile dysfunction drugs; gastroenterology; malaria treatment drugs; musculoskeletal disorders related APIs and intermediates; nephrology-urology-anti-urolithiatic products; nepirology-urology-anti-urolithiatic products; nutritional supplements/vitamins/minerals/trace elements and herbal extracts for human health care products, as well as APIs for cosmetics industries. The company was incorporated in 1935 and is headquartered in Mumbai, India.
Key slides for Cipla Limited
Q2 23/24
Cipla Limited
Q1 23/24
Cipla Limited
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇮🇳 India